Antonio Gasbarrini to Drug Synergism
This is a "connection" page, showing publications Antonio Gasbarrini has written about Drug Synergism.
Connection Strength
0.180
-
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease. Expert Opin Investig Drugs. 2018 06; 27(6):543-551.
Score: 0.142
-
Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy. Eur Rev Med Pharmacol Sci. 2019 Jul; 23(14):6379-6386.
Score: 0.038